She has helped robots learn to get around indoors and pick up balls from the ground. And she has developed computer programs ...
A new imaging technology developed at UC Davis is set to revolutionize prostatectomy, the surgery to remove prostate cancer.
Here we go again: Another study is being misrepresented as evidence that COVID vaccines cause cancer
An eminent oncologist, cancer researcher, and cancer center director is promoting a study that seems to show—but, when ...
Enrollment was between October 2019 and December 2023, during which time 41 patients were assessed for eligibility and 32 patients were enrolled. The median age was 74.0 years (range: 61.0-82.0), the ...
5don MSN
Public prostate cancer patients told treatment provided by public hospitals no longer available
Men with aggressive prostate cancer who were being treated with a groundbreaking drug have been told the therapy is no longer ...
Every October, the familiar pink ribbons return to storefronts, fundraisers and advertising campaigns, signaling Breast ...
A shorter radiation course improved quality of life among men with intermediate-risk, localized prostate cancer, according to ...
A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...
MedPage Today on MSN
Survival Benefit Evades Pelvic Radiation in Less Aggressive Prostate Cancer
Newer evidence from the POP-RT phase III trial did show that pelvic nodal radiation for high-risk, locally advanced prostate ...
News-Medical.Net on MSN
Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
Researchers report longer progression-free survival when Lutetium-177 was combined with standard radiotherapy for limited ...
SurvivorNet on MSN
A True Game-Changer in Prostate Cancer: A Simple Genomic Test Can Tell Us Who Needs Hormone Therapy And Who Doesn’t
How do we know which patients truly need this difficult treatment and which patients can safely skip it? The answer has arrived, delivered at the American Society for Radiation Oncology (ASTRO) 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results